Cardioverter defibrillators in primary prevention of sudden cardiac death: A cost or an investment?

被引:2
作者
Boriani, Giuseppe [1 ]
机构
[1] Univ Bologna, Inst Cardiol, Bologna, Italy
关键词
D O I
10.1111/j.1524-4733.2006.00138.x
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:1 / 2
页数:2
相关论文
共 11 条
[1]   Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: Randomized trial evidence through 2004 [J].
Al-Khatib, SM ;
Sanders, GD ;
Mark, DB ;
Lee, KL ;
Bardy, GH ;
Bigger, JT ;
Buxton, AE ;
Connolly, S ;
Kadish, A ;
Moss, A ;
Feldman, AM ;
Ellenbogen, KA ;
Singh, S ;
Califf, RM .
AMERICAN HEART JOURNAL, 2005, 149 (06) :1020-1034
[2]   Economics of chronic heart failure [J].
Berry, C ;
Murdoch, DR ;
McMurray, JJV .
EUROPEAN JOURNAL OF HEART FAILURE, 2001, 3 (03) :283-291
[3]   Cardioverter-defibrillators after MADIT-II: the balance between weight of evidence and treatment costs [J].
Boriani, G ;
Biffi, M ;
Martignani, C ;
Camanini, C ;
Grigioni, F ;
Rapezzi, C ;
Branzi, A .
EUROPEAN JOURNAL OF HEART FAILURE, 2003, 5 (04) :419-425
[4]  
Bryant J, 2004, HEALTH TECHNOL ASSES, V8, P1
[5]  
CARO JJ, 2007, IN PRESS VALUE HLTH, V10
[6]   The (near)equivalence of cost-effectiveness and cost-benefit analyses - Fact or fallacy? [J].
Donaldson, C .
PHARMACOECONOMICS, 1998, 13 (04) :389-396
[7]   Economic valuation through cost-benefit analysis -: possibilities and limitations [J].
Hansjürgens, B .
TOXICOLOGY, 2004, 205 (03) :241-252
[8]  
Hunt Sharon Ann, 2005, J Am Coll Cardiol, V46, pe1, DOI 10.1016/j.jacc.2005.08.022
[9]   The importance of age in allocating health care resources: does intervention-type matter? [J].
Johri, M ;
Damschroder, LJ ;
Zikmund-Fisher, BJ ;
Ubel, PA .
HEALTH ECONOMICS, 2005, 14 (07) :669-678
[10]   Diminishing proportional risk of sudden death with advancing age: Implications for prevention of sudden death [J].
Krahn, AD ;
Connolly, SJ ;
Roberts, RS ;
Tech, M ;
Gent, M .
AMERICAN HEART JOURNAL, 2004, 147 (05) :837-840